An activity-based cost accounting model of melanoma care was used to identify key cost drivers and opportunities for stakeholder innovation.
Alexa Boer Kimball, MD, MPH
Advertisement
Articles by Alexa Boer Kimball, MD, MPH
Advertisement
Latest Updated Articles
- Malignant Melanoma: The Implications of Cost for Stakeholder Innovation
Published: April 4th 2012 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Zongertinib Shows Clinically Meaningful Efficacy in Advanced HER2-Mutant NSCLC
2
Expert Discusses Logistical Considerations and Future Research Needs for Radiopharmaceuticals
3
A Common Virus May Hold New Clues to Lupus
4
SHR-A1811 Plus Pertuzumab Improves Survival in HER2-Positive Metastatic Breast Cancer
5
